Emmaus Life Sciences, Inc. - Investor Summit Group

Emmaus Life Sciences, Inc.

Ticker

EMMA

Website

Sector

Healthcare

Tearsheet

Why Invest

Commercial stage company marketing Endari® – a safe and efficacious therapy for sickle cell disease. With an FDA-recognized, favorable safety profile, Endari® is safe for pediatric and adult use and can be safely used to improve the efficacy of other therapeutics. Significant domestic and global opportunities targeting underserved sickle cell disease patient population and undeveloped therapeutic markets. A highly experienced management team with proven success in pharmaceutical research, development and commercialization led by CEO and principal inventor of Endari®, Yutaka Niihara, M.D., M.P.H.